Method Validation of Oral Non-Steroidal Anti-Inflammatory Drug: Aspirin

The objective of the present study was to develop Method Validation of Oral Non-Steroidal Anti-Inflammatory Drug: Aspirin and the release of the drug from the Oral Non-Steroidal Anti-Inflammatory. The main purpose behind process validation is to provide documented evidence that the manufacturing process of Aspirin 400 mg coated tablet meets the predefined control parameters. This involves in-process monitoring of critical processing steps and end product testing of current production can document evidence to show that the manufacturing process is in a state of control.